Shuo Wang
Impact in
- Immunology top 5%
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Inflammasome and immune disorders 11
- RNA modifications and cancer 7
- Oncology 56
- Cancer Immunotherapy and Biomarkers 21
- Cytokine Signaling Pathways and Interactions 8
- Cancer Cells and Metastasis 6
- Co-authors
- Zhi‐Jun Sun (31 shared papers)Qi‐Chao Yang (21 shared papers)Nai‐Hong Chen (1 shared paper)Yu‐He Yuan (1 shared paper)Hongbo Wang (1 shared paper)Shu‐Cheng Wan (13 shared papers)Yao Xiao (8 shared papers)Liang Zhang (4 shared papers)
- Journals
- Frontiers in Oncology (9 papers)Scientific Reports (5 papers)Nature Communications (4 papers)Oral Diseases (3 papers)Journal of Cancer (3 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Shuo Wang
139 papers receiving 3.8k citations
Shuo Wang's Hit Papers
Peers
Comparison fields: 5 of 128
- Immunology 780
- Oncology 795
- Cancer Research 414
- Molecular Biology 1.8k
- Biomedical Engineering 654
Countries citing papers authored by Shuo Wang
This map shows the geographic impact of Shuo Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuo Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuo Wang more than expected).
Fields of papers citing papers by Shuo Wang
This network shows the impact of papers produced by Shuo Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuo Wang. The network helps show where Shuo Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Shuo Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 146 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson's disease Hit paper breakdown → | 2018 | 380 |
| 2 | 2021 | 165 | |
| 3 | 2013 | 160 | |
| 4 | Integration of AIEgens into covalent organic frameworks for pyroptosis and ferroptosis primed cancer immunotherapy Hit paper breakdown → | 2023 | 156 |
| 5 | 2019 | 154 | |
| 6 | 2015 | 119 | |
| 7 | 2019 | 104 | |
| 8 | 2021 | 103 | |
| 9 | 2021 | 94 | |
| 10 | 2018 | 93 | |
| 11 | 2022 | 92 | |
| 12 | 2020 | 85 | |
| 13 | 2022 | 85 | |
| 14 | 2017 | 84 | |
| 15 | 2014 | 84 | |
| 16 | 2022 | 80 | |
| 17 | 2018 | 74 | |
| 18 | 2018 | 59 | |
| 19 | 2024 | 54 | |
| 20 | 2020 | 53 |
About Shuo Wang
Shuo Wang is a scholar working on Molecular Biology, Oncology, Immunology, Epidemiology and Pulmonary and Respiratory Medicine, having authored 146 papers that have together received 3.9k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (21 papers), Inflammasome and immune disorders (11 papers), Nanoplatforms for cancer theranostics (10 papers), Autophagy in Disease and Therapy (9 papers), Immune cells in cancer (9 papers), Cytokine Signaling Pathways and Interactions (8 papers), RNA modifications and cancer (7 papers) and Cancer Cells and Metastasis (6 papers). The work is most often cited by research in Immunology (780 citations), Oncology (795 citations), Cancer Research (414 citations), Molecular Biology (1.8k citations) and Biomedical Engineering (654 citations). Shuo Wang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Zhi‐Jun Sun, Qi‐Chao Yang, Nai‐Hong Chen, Yu‐He Yuan, Hongbo Wang, Shu‐Cheng Wan, Yao Xiao, Liang Zhang, Hexiang Deng and Zusen Fan. Their work appears in journals such as Frontiers in Oncology, Scientific Reports, Nature Communications, Oral Diseases and Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.